FORTRESS BIOTECHPRFA (Germany) Top Insiders

CNB0 Stock  EUR 7.05  0.10  1.44%   
Examination of FORTRESS BIOTECHPRFA's management performance can provide insight into the company performance.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in FORTRESS BIOTECHPRFA 25. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Symbol  CNB0
Name  FORTRESS BIOTECHPRFA 25
TypeStock
Country  
 Germany
Exchange  F

Information on FORTRESS BIOTECHPRFA 25 Leadership is currently not available.

If you believe this information is not accurate please let us know and we will check it out. Check all delisted instruments across multiple markets.

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

FORTRESS BIOTECHPRFA Management Team Effectiveness

The company has return on total asset (ROA) of (0.3494) % which means that it has lost $0.3494 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.4338) %, meaning that it generated substantial loss on money invested by shareholders. FORTRESS BIOTECHPRFA's management efficiency ratios could be used to measure how well FORTRESS BIOTECHPRFA manages its routine affairs as well as how well it operates its assets and liabilities.

FORTRESS BIOTECHPRFA Workforce Comparison

FORTRESS BIOTECHPRFA 25 is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 282,125. FORTRESS BIOTECHPRFA adds roughly 173 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
The company has Profit Margin (PM) of (1.17) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (2.63) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $2.63.

FORTRESS BIOTECHPRFA Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. FORTRESS BIOTECHPRFA Price Series Summation is a cross summation of FORTRESS BIOTECHPRFA price series and its benchmark/peer.

About FORTRESS BIOTECHPRFA Management Performance

The success or failure of an entity such as FORTRESS BIOTECHPRFA often depends on how effective the management is. FORTRESS BIOTECHPRFA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of FORTRESS management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the FORTRESS management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in New York, New York. FORTRESS BIOTECH operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 111 people.

Complementary Tools for FORTRESS Stock analysis

When running FORTRESS BIOTECHPRFA's price analysis, check to measure FORTRESS BIOTECHPRFA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FORTRESS BIOTECHPRFA is operating at the current time. Most of FORTRESS BIOTECHPRFA's value examination focuses on studying past and present price action to predict the probability of FORTRESS BIOTECHPRFA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FORTRESS BIOTECHPRFA's price. Additionally, you may evaluate how the addition of FORTRESS BIOTECHPRFA to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments